KRISTINA TRANELL: Open Payments
NPI 1255040556 · HAVERTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,488 in 125 payments from 19 companies in 2025. Trend: 2023 $1,726 · 2024 $1,932 · 2025 $2,488
Food & beverage: $2,402Education: $87
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 22 | $465 |
| Regeneron Healthcare Solutions, Inc. | 15 | $316 |
| GlaxoSmithKline, LLC. | 13 | $263 |
| Novartis Pharmaceuticals Corporation | 12 | $229 |
| Genentech USA, Inc. | 7 | $177 |
| GENZYME CORPORATION | 7 | $173 |
| BioCryst US Sales Co., LLC | 8 | $152 |
| Optinose US, Inc. | 15 | $150 |
| CSL Behring | 6 | $137 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $105 |
Products named: DUPIXENT, TEZSPIRE, Xolair, TRELEGY ELLIPTA, Xhance, ORLADEYO, NEFFY, NUCALA.
Industry payments across PA — which companies pay providers there.
